Here are the latest new cancer drugs approved by the Food and Drug Administration:

  • Adstiladrin (firadenovec) for bladder cancer
  • Elahere (mirvetuximab soravtansine) for ovarian cancer
  • Imjudo (tremelimumab) for liver cancer
  • Jaypirca (pirtobrutinib) for mantle cell lymphoma
  • Krazati (adagrasib) for non-small-cell lung cancer
  • Lunsumio (mosunetuzumab) for follicular lymphoma
  • Lytgobi (futibatinib) for cholangiocarcinoma
  • Orserdu (elacestrant) for advanced breast cancer
  • Rezlidhia (olutasidenib) for acute myeloid leukemia
  • Tecvayli (teclistamab) for multiple myeloma